
PMC:7781431 / 827-1007
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
33 | 99-126 | Species | denotes | respiratory syncytial virus | Tax:12814 |
34 | 128-156 | Species | denotes | human immunodeficiency virus | Tax:12721 |
35 | 162-179 | Species | denotes | hepatitis C virus | Tax:11103 |
41 | 3-20 | Chemical | denotes | -resolving lipids |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T3 | 134-150 | Phenotype | denotes | immunodeficiency | http://purl.obolibrary.org/obo/HP_0002721 |
T4 | 162-171 | Phenotype | denotes | hepatitis | http://purl.obolibrary.org/obo/HP_0012115 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T7 | 0-180 | Sentence | denotes | Pro-resolving lipids mediators have shown great promise for the treatment of Herpes simplex virus, respiratory syncytial virus, human immunodeficiency virus, and hepatitis C virus. |